LEAD Grants are one of the many ways CSL Behring is committed to improving the quality of life for people with rare diseases who utilize plasma-derived or recombinant therapies.
As a leader in advocacy, CSL Behring partners with patient organizations to address important public policy issues. LEAD Grants are awarded annually to help patient organizations achieve their advocacy objectives.
How to Apply:
Complete and submit the grant application request form. Applications will be judged on the appropriateness of the proposed usage and the advocacy issue being addressed.
Deadlines for submitting LEAD Grants proposals are April 30 and October 31. The grants are awarded annually in June and December.
Download the Grant Application Form in
Adobe Acrobat PDF
Microsoft Word format.